Home/Filings/4/0001209191-19-007238
4//SEC Filing

Andrews William T. 4

Accession 0001209191-19-007238

CIK 0001069308other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 1:49 PM ET

Size

5.7 KB

Accession

0001209191-19-007238

Insider Transaction Report

Form 4
Period: 2019-02-01
Andrews William T.
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-02-01+27,00027,000 total
    Exercise: $24.46Exp: 2029-02-01Common Stock (27,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable over four years as follows: 25% of the shares vest on February 1, 2020, and 1/16th of the shares vest each quarter thereafter for the remaining three years.

Issuer

Acer Therapeutics Inc.

CIK 0001069308

Entity typeother

Related Parties

1
  • filerCIK 0001638459

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 1:49 PM ET
Size
5.7 KB